CRISPR-Cas: an adaptive immunity system in prokaryotes by Koonin, Eugene V & Makarova, Kira S
CRISPR-Cas: an adaptive immunity system in prokaryotes
Eugene V Koonin* and Kira S Makarova
Address: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike,
Bethesda, MD 20894, USA
*Corresponding author: Eugene V Koonin (koonin@ncbi.nlm.nih.gov)
F1000 Biology Reports 2009, 1:95 (doi: 10.3410/B1-95)
The electronic version of this article is the complete one and can be found at: http://F1000.com/Reports/Biology/content/1/95
Abstract
Most of the archaea and numerous bacteria possess an elaborate system of adaptive immunity to
mobile genetic elements known as the CRISPR (clustered regularly interspaced short palindromic
repeats)-associated system (CRISPR-Cas), which consists of arrays of short repeats interspersed with
unique DNA spacers and adjacent operons encompassing CRISPR-associated (cas) genes with
predicted and, in some cases, experimentally validated nuclease, helicase, and polymerase activities.
The system functions by integrating fragments of alien DNA between the repeats and employing their
transcripts to degrade the DNA of the respective invading elements via an RNA interference-like
mechanism. The CRISPR-Cas system is a case of apparent Lamarckian inheritance.
Introduction and context
A brief history of the serendipitous discovery
of a prokaryotic immune system
Bacteria and archaea exist in an incessant arms race with
various selfish genetic elements (phages, transposons,
and plasmids) and have evolved a variety of defense
systems. The best known ones probably are the
numerous restriction-modification enzyme systems that
exploit different methylation patterns of host and
infecting agent DNA to eliminate the invader [1].
Recently, a novel widespread defense system that
functions on a completely different principle was
discovered; it became known as the CRISPR (clustered
regularly interspaced short palindromic repeats)-
associated system, usually referred to as CRISPR-Cas
(where Cas stands for CRISPR-associated proteins) or,
alternatively, as CASS [2-4]. The discovery of this system
involved considerable intrigue and serendipity. Distinct
arrays of short repeats interspersed with unique spacers
(CRISPR) have been seen in bacterial and archaeal
genomes for years, with no clues as to their possible
functions [5,6]. Independently, Cas protein sequences
encoded by putative operons adjacent to CRISPR [7]
were analyzed in detail and found to contain domains
characteristic of several nucleases, a helicase, a
polymerase, and RNA-binding proteins; it has been
suggested that these proteins might belong to a novel
repair system [8]. A new light was shed on the probable
function of the CRISPR when it was observed that some
of the unique inserts were (nearly) identical to fragments
of phage and plasmids genes, a pivotal observation that
immediately led to the idea that CRISPR might be
involved in defense against selfish elements [9-11]. These
findings were combined with the results of comprehen-
sive computational re-analysis of the Cas proteins to
develop a detailed hypothesis on the mechanism of
CRISPR-Cas [12]. This hypothesis drew a close analogy
between the putative novel prokaryotic defense system
and the eukaryotic RNA interference (RNAi) mechanisms
[13], with the important difference that CASS mediates
integration of a piece of alien DNA into the host genome
as the first step in the sequence of events which leads to
immunity to the given agent [12]. Specific roles for
individual Cas proteins were proposed as well on the
basis of their domain composition and by analogy with
RNAi components although the proteins involved are
not homologous [12]. This hypothesis prompted direct
experiments that demonstrated that engineering a
specific bacteriophage sequence into the CRISPR locus
of the lactic bacterium Streptococcuss thermophilus indeed
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was abrogated by even a single mismatch between the
insert and the target gene [14]. These key experiments
clinched the case for the defense role of CRISPR-Cas and
triggered an avalanche of further genetic and biochem-
ical experiments.
Major recent advances
Comparative genomics, diversity, and evolution
of CRISPR-Cas systems
CRISPR-Cas is a highly diverse constellation of genes,
with the number of CRISPR-cas loci, cas gene repertoire,
and (predicted) operon organization often changing
even between closely related strains [3,12,15-18]. Com-
parative analysis of operon architectures revealed seven
distinct types of CRISPR-Cas, each of which is character-
ized by a distinct signature of genomic architecture [12].
Only two genes, cas1 and cas2, are invariably present in
each CRISPR-Cas system so far detected and accordingly
can be used as genomic markers of CRISPR-Cas. In
addition to the two universal genes, three genes (cas3,
cas4, and cas5) are present in the majority of CRISPR-Cas,
and approximately 20 other genes are found in various
subsets of these systems [12,15]. Cas5 and several other
less common CRISPR-Cas components belong to the
large and extremely diverged superfamily of repeat-
associated mysterious proteins (RAMPs) [12,15].
Using the highly conserved Cas1 protein sequence as
a marker, we detected CRISPR-Cas in 297 of the 774
analyzed prokaryotic genomes (37%); among archaea,
CRISPR-Cas is much more common than among
bacteria: up to 90% of the available archaeal genomes
carry CRISPR-Cas (Figure 1). The representation of
CRISPR-Cas in the genomes of diverse groups of archaea
and bacteria differs within a broad range, from ubiquity
to complete absence (although it should be noted that
all groups completely lacking CRISPR-Cas are currently
represented by a small number of genomes) (Figure 1).
Phylogenetic analysis of core cas genes, such as cas1 and
cas3, fails to recover major bacterial and archaeal
lineages, an observation that appears to be indicative
of extensive mobility of CRISPR-cas modules via
horizontal gene transfer (HGT). The cas genes are not
only horizontally mobile but also typically show high
rates of sequence evolution, with the partial exception of
core genes, in particular cas1 [12,15]. In many cases, this
fast evolution renders sequence conservation between
homologous Cas proteins barely detectable, most con-
spicuously among the RAMPs, which are propagated by
both gene duplication and HGT and constitute a large
fraction of Cas protein sets in most CRISPR-Cas-carrying
prokaryotes [12]. The RAMPs are extremely diverged in
sequence, so that the demonstration that different RAMP
families were related and possessed the same fold
required the careful use of the most sensitive sequence
analysis methods (and even so, it is likely that additional
RAMPs have been missed). Conceivably, RAMPs and
perhaps some other Cas proteins evolve under positive
selection dictated by the arms race with selfish elements
[19,20]. This possibility is congruent with the observa-
tions that, although virus or plasmid origin is apparent
for a considerable number of CRISPR spacers, the
majority of the spacers are not significantly similar to
any sequences in current databases [9,19,20]. In addi-
tion, deletion of CRISPR units (a repeat with a spacer)
has been demonstrated [21]. Thus, it appears, first, that
Figure 1. Representation of the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas system in archaeal and bacterial
lineages
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The bars show the fractions of sequenced genomes in each group that possess CRISPR-Cas (red) and lack CRISPR-Cas (blue). The actual numbers of
available genomes are also indicated for both parts of each bar. The figure is based on the results of screening of the proteins encoded in 774 archaeal
and bacterial genomes for statistically significant sequence similarity to Cas1 sequences using BLASTP [32].
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archaea and bacteria is vast, and second, that the CRISPR-
Cas-mediated immunity is short-lived; that is, spacers
rapidly deteriorate by mutation once the cognate
element is no longer a threat [19].
Taken together, these observations identify the CRISPR-
Cas as a bona fide component of the prokaryotic
mobilome [that is, the totality of genetic elements that
are characterized by extensive horizontal mobility and
include selfish elements (viruses, plasmids, transposons,
and so on) as well as defense and stress response
systems] [22,23]. Notably, CRISPR-cas loci are often
located within ‘defense islands’ (i.e., regions of bacterial
and archaeal genomes that consist primarily of genes
encoding defense and stress response systems, such as
restriction-modification and toxin-antitoxin modules)
[24]. This genomic association permits the prediction of
novel prokaryotic defense systems. Comparative-
genomic analysis of the CRISPR-cas loci is facilitated by
the use of specialized databases and accompanying
custom software tools for CRISPR detection [25].
Molecular mechanisms of CRISPR-Cas and functions
of Cas proteins
CRISPR-Cas systems mediate immunity to invading
genetic elements via three distinct stages: (a) adaptation,
(b) expression and processing of CRISPR, and (c)
interference [3]. The full molecular picture is far from
being clear for each of these stages, but recently several
fundamental results, particularly on the processing of
CRISPR transcripts, have been reported. With regard to
the adaptation stage, following the original work that
demonstrated the insertion of a phage-specific spacer
into the CRISPR locus of Streptococcus thermophilus, this
process was explored systematically, leading to the
conclusion that a phage challenge typically triggers
insertion of a single phage-specific resistance-conferring
spacer with a characteristic length of 30 base pairs;
successive infection of a bacterial culture with multiple
phages led to the accumulation of the cognate spacers in
the CRISPR loci [21]. Furthermore, it has been shown
that insertion of new spacers depends on short PAMs
(proto-spacer adjacent motifs), which differ between
variants of the CRISPR-Cas system and might determine
the identity of the inserted spacer [26].
The original ‘prokaryotic RNAi’ hypothesis maintained
thatCRISPR-CassystemswouldtargetmRNAsofinvading
agents [12]. However, the first experiments that, in
general, validated the hypothesis have also shown that
both strands of the CRISPR spacer DNA were effective in
conferringimmunitytothecognatephage,anobservation
best compatible with a DNA target [14]. A more direct
experiment showed that the insertion of a self-splicing
intron into the target gene made the respective plasmid
resistant to the CRISPR-mediated immunity, a clear
indication that the invading DNA itself is targeted [27].
Whether this conclusion is general and applies to all
CRISPR-Cas remains to be determined, especially given
the extreme diversity of the architectures of these systems.
As of September 2009, biochemical activities and/or
crystal structures of several widespread Cas proteins have
been determined (Table 1) [3]. In agreement with the
computational predictions and nuclease activities, either
RNAse or DNAse or both were demonstrated for several
Cas proteins. Notably, these novel nucleases include both
universal Cas proteins. Specifically, Cas1 has been shown
to be a metal-dependent DNAse with no sequence
specificity and has been implicated in the integration of
the alien DNA into the CRISPR cassettes [28]. Cas2 has
been characterized as a metal-dependent endoribonu-
clease whose role in the CRISPR-Cas mechanism remains
unclear [29]. A striking finding is that some of the RAMP
proteins that contain a double ferredoxin-fold domain
and were originally proposed to be non-enzymatic RNA-
binding proteins (considering their extreme sequence
divergence [12]), actually possess RNAse activity that is
apparently involved in the processing of CRISPR tran-
scripts [30,31]. In particular, a RAMP protein seems to be
the active moiety of the CASCADE (CRISPR-associated
complex for antiviral defense) complex that consists of
five Cas proteins (Table 1) and is the CRISPR-processing
machine of Escherichia coli [30]. In concert with the Cas3
protein that consists of (predicted) helicase and nuclease
domains, CASCADE seems to be involved in the
interference stage.
Future directions
Comparative-genomic predictions validated by a rapidly
growing body of experimental results indicate that the
CRISPR-Cas is an adaptive immunity system that is
widely employed by archaea and bacteria for defense
against diverse invading elements, in particular, viruses.
The system functions by integrating fragments of alien
element genes into CRISPR loci and employing the
resulting spacers, after transcription and processing, as
guide RNAs to abrogate the replication of the cognate
elements by cleaving nucleic acid molecules comple-
mentary to the guide. In some cases, at least, the target of
CRISPR-Cas is the genomic DNA of an invading genetic
element. Experiments aimed at molecular dissection of
CASS proved the predicted principle of its action and are
starting to reveal multiple activities of the protein
components of CASS and the molecular architecture of
complexes formed by these proteins. However, an
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done to elucidate the mechanisms of CASS, in particular,
the molecular details of spacer incorporation into the
CRISPR loci and the specific pathways of RNA-guided
destruction of alien genomes. These experiments can be
expected to reveal the considerable mechanistic diversity
that reflects the extreme diversity of cas gene repertoires and
operonic organization. Another important direction of
future work is the characterization of the arms race between
CRISPR-Cas and viruses of prokaryotes and elucidation of
putative mechanisms of counterdefense employed by the
viruses. Finally, it is worth noting that, by integrating
fragments of invaders’ genomes into the genomes of the
archaeal and bacterial hosts, the CASS effectively operates
via a Lamarckian-type inheritance of acquired characters.
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Table 1. Cas proteins and complexes: predicted and experimentally determined biochemical activities and possible functions in
CRISPR-mediated immunity
Protein
a Representation in
CRISPR-Cas
b
Domain organization
b Predicted activity and
function
b
Three-dimensional
structure
c
Experimentally demon-
strated activity and/or
function
Cas1 (COG1518) Universal Highly conserved
domain without detect-
able similarity to other
proteins
Nuclease, possibly
integrase; role in adap-
tation (integration of
invader DNA)
3GOD: unique mostly
a-helical fold [28]
Metal-dependent
nuclease, cleaves both
DNA and RNA [28]
Cas2 (COG1343,
COG3512, and addi-
tional small families)
Universal (except for
some probably
non-functional CASS
variants)
Small domain distantly
related to VapD, an
uncharacterized
bacterial protein linked
to toxin-antitoxin
system; some fusions
with Cas3
Nuclease, possible role
in adaptation
2IVY, 2I8E: ferredoxin-
like fold [29]
Sequence-specific
endoribonuclease [29]
Cas3 (COG1203) Present in a substantial
majority of CASS, with
the exception of several
reduced though possibly
functional systems
Superfamily 2 helicase,
typically fused to HD
nuclease; in some CASS
variants, helicase and
nuclease are encoded by
adjacent genes
Helicase-nuclease,
possible roles at all
stages of CASS-
mediated immunity
None Interacts with
CASCADE, contributes
to CASS-mediated
interference [30];
endonuclease activity
demonstrated from a
stand-alone HD-protein
from Sulfolobus [33]
Cas4 (COG1468,
COG4343)
Present in a substantial
majority of CASS, with
the exception of several
reduced though possibly
functional systems
RecB-like nuclease
domain and an
additional metal-binding
module
Nuclease, implicated in
adaptation
None None
RAMPs (Cas5
[COG1688], Cas6
[COG1583], COGs
1769, 1567, 1336,
1367, 1604, 1337,
1332, 5551, and
additional small
families)
Diverse subsets of
RAMPs present in all
CASS
RAMP RNA-binding proteins,
probably sequence-
structure-specific
1WJ9, 3I4H Duplicated
ferredoxin-fold domain
Cas5 in Escherichia coli is
a CASCADE subunit
and directly cleaves
CRISPR transcripts
generating guide RNAs
[30]; Cas6 performs the
same function in
Pyrococcus [31]
CASCADE
[CasABCDE(Cse1234-
Cas5e) complex]
E. coli; different
combinations of sub-
units in other
prokaryotes
Cas5e (COG1688) is a
RAMP; other domains
uncharacterized
Cse4 (COG1857):
predicted nuclease;
Cas5e: predicted RNA-
binding protein
See above for Cas5. CasC is the principal
structural subunit;
Cas5e is the nuclease
subunit [30].
aThese are only the most widespread and experimentally characterized Cas proteins; there is no unified nomenclature of Cas proteins [3]; the Cas protein
names are accompanied by the numbers of clusters of orthologous genes (COGs) [34] where available.
bData are from references [3] and [12].
cStructures
are identified by Protein Data Bank accession numbers. Cas, CRISPR (clustered regularly interspaced short palindromic repeats)-associated protein;
CASCADE, CRISPR (clustered regularly interspaced short palindromic repeats)-associated complex for antiviral defense; CASS, CRISPR (clustered regularly
interspaced short palindromic repeats)-associated system; CRISPR, clustered regularly interspaced short palindromic repeats; HD, HD (histidine-aspartate)-
family nuclease; RAMP, repeat-associated mysterious protein.
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